Wai Chun Bio-Tech (660) Announces Board Meeting to Review Interim Results
Bulletin Express
Feb 12
Wai Chun Bio-Technology Limited (Stock Code: 660) has scheduled a board meeting on 27 February 2026 at Rooms 4001–02, 40th Floor, China Resources Buildings, 26 Harbour Road, Wanchai, Hong Kong. According to the announcement dated 12 February 2026, the meeting will focus on considering and approving the unaudited interim results for the six months ended 31 December 2025, as well as the publication of those results.
The board of Wai Chun Bio-Technology Limited currently comprises one executive director, Chairman and Chief Executive Officer, Mr. Lam Ka Chun, alongside three independent non-executive directors: Mr. Wong Po Keung, Mr. Wang Ziniu, and Ms. Xu Huiling.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.